iBio Inc (AMEX:IBIO)
$ 1.92 -0.062 (-3.13%) Market Cap: 16.56 Mil Enterprise Value: 28.59 Mil PE Ratio: 0 PB Ratio: 0.66 GF Score: 36/100

Q1 2022 Ibio Inc Earnings Call Transcript

Nov 15, 2021 / 09:30PM GMT
Release Date Price: $375 (-1.32%)
Operator

Good day, and thank you for standing by. Welcome to the iBio Fiscal 2022 First Quarter Financial Results Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question-and-answer session. (Operator Instructions)

I would now like to hand the conference over to Stephen Kilmer, iBio Investor Relation. Please go ahead, sir.

Stephen Kilmer
iBio, Inc. - Investor Relations

Thank you. Good afternoon, everyone. Before we begin, I would like to remind you that during this call, the company will be making forward-looking statements regarding our current expectations and projections about future events that are subject to risks and uncertainties.

Reference to these risks and uncertainties are made in today's press release as of closed and detailed on the company's periodic and current filings with the U.S. Securities and Exchange Commission. No forward-looking statements can be guaranteed. And actual result may differ from the results discussed in these forward-looking statements.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot